Circulating tumor cells (CTCs) are single cells or clusters of cells within the circulatory
system of a cancer patient. While most CTCs will perish, a small proportion will proceed to …

Circulating tumour cells (CTCs) are emerging as important prognostic markers and have
potential clinical utility as tumour biomarkers for targeted cancer therapy. Although CTCs …

Circulating tumor cells (CTCs) represent a surrogate biomarker of hematogenous
metastases. In recent years, their detection has gained increasing interest. There is ample …

Circulating tumor cells (CTCs) could be considered a sign of tumor aggressiveness, but
highly sensitive and specific methods of CTC detection are necessary owing to the rarity and …

Circulating tumor cells (CTC) detected in the blood of cancer patients could be used for risk-
stratification, molecular subclassification and as an intermediate end-point in therapeutic …

Circulating tumor cells (CTCs) are believed to be responsible for the development of
metastatic disease. Over the last several years there has been a great interest in …

Metastases and cancer recurrence are the main causes of cancer death. Circulating Tumor
Cells (CTCs) and disseminated tumor cells are the drivers of cancer cell dissemination. The …

Circulating tumor cells (CTCs) that are detached from the tumor can be precursors of
metastasis. The majority of studies focus on enumeration of CTCs from patient blood to …

Detection and analysis of circulating tumor cells (CTCs) from patients with metastatic
malignancies have become active areas of research in recent years. CTC enumeration has …

In most solid tumors, it is distant metastases rather than the primary tumor which limit the
prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively …